Sponsors dig into CapVest’s Curium ahead of initial bids 

JPM and Rothschild are providing financial advice to the nuclear medicine company.

12 December 2019•3 mins read
CapVest Partners, Curium Pharmaceuticals
LinkedInXEmail
LinkedInXEmail

Related articles